EU set to improve availability of new medicines in Slovakia
The European Commission wants to harmonize the availability of new medicines across countries. Slovakia is a laggard in this respect. In Germany, Austria, and Denmark, for example, more than 100 new medicines approved by the European Medicines Agency two years earlier hit the market in 2018. The Slovak figure was just 55 and Czech as low as 43. The EC particularly wants to support generic medicines, which tend to be cheaper. It also wants to present a list of critical medicines that should be available in all EU countries.
